🚀 Apply for £10k+ grants with our Startup Launch Kit
shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical Trial Data Processing, Analysis, and Coordination Center

    FOR-MH-26-205

    Suzanne Garcia, PhD National Institute of Mental Health (NIMH)

    Opening date 17 Jun 2025, 12:00AM

    Closing date N/A

    Funding Opportunity Number: FOR-MH-26-205

    Opportunity Category: Discretionary

    Expected Number of Awards: 1

    CFDA Number(s): 93.242 -- Mental Health Research Grants

    Cost Sharing or Matching Requirement: No

    Posted Date: Jun 17, 2025 12:00:00 AM EDT

    Closing Date: N/A

    Estimated Total Program Funding: 12000000

    Eligible Applicants: Public and State controlled institutions of higher education,Small businesses,Public housing authorities/Indian housing authorities,Native American tribal organizations (other than Federally recognized tribal governments),Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,State governments,Private institutions of higher education,Native American tribal governments (Federally recognized),Independent school districts,County governments,For profit organizations other than small businesses

    Description:

    The National Institute of Mental Health (NIMH) intends to publish a single source Notice of Funding Opportunity (NOFO) to renew support of the Accelerating Medicines Partnership Schizophrenia (AMP SCZ) Clinical High Risk for Psychosis Clinical Trial Data Processing, Analysis, and Coordination Center, to continue core program activities, such as management, direction, and coordination, including data processing and analysis to support the AMP SCZ Clinical Trial Network awarded under RFA-MH-24-150. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop a responsive application. This NOFO will utilize the U24 activity code. Investigators from Brigham and Women's Hospital awarded under RFA-MH-24-151 with expertise and insights in coordinating a wide scope of activities, including working with clinical research organizations, to support the use of pharmacological interventions for psychosis are encouraged to consider applying for this NOFO. In addition, collaborative investigations combining expertise in bioinformatics and data processing appropriate to establish and implement the procedures for collecting, processing, and analyzing specialized biomarker and digital data types, including multi-modal data analysis should also consider collaborating for this application. 

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept